Drug

Sulfadiazine

90 flagged reaction(s) · 3,333 total co-reports · max PRR 125.6

Important: Reactions below are the flagged terms from this drug’s FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate disproportionality in spontaneous reporting, not causation. Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.

	Reaction	Co-reports (a)	PRR	ROR	Signal
1	Obstructive Airways Disorder	111	125.6	134.4	signal
2	Full Blood Count Abnormal	102	122.1	130.0	signal
3	Vasculitis	106	114.7	122.4	signal
4	Arteriosclerosis	77	103.0	107.9	signal
5	Sleep Disorder Due To A General Medical Condition	107	83.3	88.9	signal
6	Nodule	81	78.1	82.0	signal
7	Pulmonary Fibrosis	113	74.4	79.7	signal
8	Haemoptysis	113	50.7	54.3	signal
9	Hypothyroidism	109	42.9	45.9	signal
10	Toxic Epidermal Necrolysis	47	39.1	40.2	signal
11	Lung Disorder	116	29.7	31.8	signal
12	Hypoxia	77	27.5	28.8	signal
13	Loss Of Personal Independence In Daily Activities	99	26.1	27.7	signal
14	Wheezing	107	22.7	24.1	signal
15	Therapeutic Product Effect Incomplete	122	21.6	23.2	signal
16	Productive Cough	80	21.2	22.2	signal
17	Pancytopenia	79	17.7	18.6	signal
18	Bone Marrow Failure	27	16.5	16.8	signal
19	Pneumonia Aspiration	30	15.1	15.3	signal
20	End Stage Renal Disease	22	15.0	15.1	signal
21	Nephropathy	11	14.7	14.8	signal
22	Drug Reaction With Eosinophilia And Systemic Symptoms	27	13.2	13.4	signal
23	Asthma	115	12.8	13.7	signal
24	Pancreatitis	54	12.8	13.2	signal
25	Gastrointestinal Pain	11	12.6	12.6	signal
26	Rash Maculo-papular	22	12.4	12.6	signal
27	Drug Hypersensitivity	190	12.2	13.7	signal
28	Pharyngitis	12	12.1	12.1	signal
29	Stevens-johnson Syndrome	21	11.8	11.9	signal
30	Thrombosis	74	11.5	12.0	signal
31	Central Nervous System Lesion	12	10.9	10.9	signal
32	Pulmonary Embolism	81	10.6	11.1	signal
33	Incorrect Route Of Product Administration	14	10.4	10.5	signal
34	Chronic Kidney Disease	58	9.5	9.8	signal
35	Adverse Reaction	10	9.4	9.5	signal
36	Eosinophilia	13	9.3	9.4	signal
37	Coma	35	9.2	9.4	signal
38	Muscle Spasticity	9	9.1	9.1	signal
39	Coagulopathy	12	9.0	9.1	signal
40	Musculoskeletal Disorder	13	8.5	8.6	signal
41	Candida Infection	11	8.2	8.3	signal
42	Eating Disorder	14	8.2	8.3	signal
43	Hepatic Cytolysis	8	8.2	8.2	signal
44	Grand Mal Convulsion	6	8.0	8.0	signal
45	Lymphopenia	9	8.0	8.0	signal
46	Brain Oedema	8	7.9	8.0	signal
47	Hypophagia	16	7.9	8.0	signal
48	Cholestasis	12	7.9	7.9	signal
49	Cardiomyopathy	9	7.6	7.6	signal
50	Adrenal Insufficiency	7	7.3	7.3	signal
51	Liver Injury	14	7.2	7.3	signal
52	Petechiae	6	7.2	7.2	signal
53	Deafness	15	7.2	7.2	signal
54	Abscess	9	7.1	7.1	signal
55	Leukopenia	28	7.0	7.1	signal
56	Feeding Disorder	11	6.9	6.9	signal
57	Condition Aggravated	163	6.8	7.4	signal
58	Drug Ineffective For Unapproved Indication	30	6.7	6.8	signal
59	Pharyngeal Swelling	5	6.5	6.5	signal
60	Multi-organ Failure	9	6.4	6.4	signal
61	Impaired Work Ability	11	6.4	6.5	signal
62	Hepatocellular Injury	7	6.2	6.2	signal
63	No Therapeutic Response	6	6.1	6.1	signal
64	Muscle Atrophy	6	6.0	6.0	signal
65	Nephropathy Toxic	5	5.6	5.6	signal
66	Pain In Extremity	132	5.6	6.0	signal
67	Rash Papular	10	5.6	5.6	signal
68	Skin Exfoliation	35	5.3	5.4	signal
69	Cytomegalovirus Infection	7	5.3	5.3	signal
70	Polyneuropathy	5	5.3	5.3	signal
71	Cytopenia	5	5.2	5.2	signal
72	Haemorrhage Intracranial	6	5.0	5.0	signal
73	Contraindicated Product Administered	12	5.0	5.0	signal
74	Toxic Skin Eruption	4	5.0	5.0	signal
75	Neutropenia	52	4.8	4.9	signal
76	Agranulocytosis	7	4.7	4.8	signal
77	Breast Pain	4	4.7	4.7	signal
78	Blood Thyroid Stimulating Hormone Increased	3	4.1	4.1	signal
79	Libido Decreased	4	4.0	4.0	signal
80	Drug Resistance	8	3.9	3.9	signal
81	Vaginal Discharge	3	3.7	3.7	no signal
82	Premature Baby	9	3.7	3.7	signal
83	Drug Toxicity	4	3.6	3.6	signal
84	Underdose	21	3.6	3.6	signal
85	Drug Dispensing Error	4	3.2	3.2	signal
86	Drug Exposure During Pregnancy	8	2.9	2.9	signal
87	Rheumatoid Arthritis	25	2.8	2.8	signal
88	Foetal Exposure During Pregnancy	12	1.8	1.9	no signal
89	Myelosuppression	5	1.8	1.8	no signal
90	Gynaecomastia	4	1.6	1.6	no signal